Cargando…
Acute Severe Thrombocytopenia Occurring After Administration of Eptifibatide Postpones Emergent Coronary Artery Surgery
INTRODUCTION: Eptifibatide is a platelet glycoprotein IIb/IIIa (GP IIb/IIIa) receptor antagonist that inhibits fibrinogen binding to the activated GP IIb/IIIa site and prevents platelet-platelet interaction and clot formation. GP IIb/IIIa inhibitors improve outcome in patients undergoing percutaneou...
Autores principales: | Boettcher, Brent T., Olund, Timothy J., Pagel, Paul S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099974/ https://www.ncbi.nlm.nih.gov/pubmed/27843778 http://dx.doi.org/10.5812/aapm.37575 |
Ejemplares similares
-
Profound thrombocytopenia after primary exposure to eptifibatide
por: Norgard, Nicholas B, et al.
Publicado: (2010) -
A rare case of eptifibatide-induced thrombocytopenia
por: Kamar, Khalil, et al.
Publicado: (2021) -
Eptifibatide-induced acute profound thrombocytopenia: a case report
por: Graidis, Christos, et al.
Publicado: (2014) -
Acute Stent Thrombosis Associated with Eptifibatide-Induced Profound Thrombocytopenia
por: Aljundi, Amer, et al.
Publicado: (2020) -
Eptifibatide-induced acute profound thrombocytopenia: A case report
por: Alamin, Mohammed A., et al.
Publicado: (2022)